Method and materials for development of immunological responses

Details Method and materials for development of immunological responses Method and materials for development of immunological responses

1983-08-19

1988-08-30

Wiseman, Thomas G.

Drug, bio-affecting and body treating compositions

Lymphokine

530350, 530403, 530822, 435 68, 435 70, A61K 3900, C12P 2100, C07G 700

Patent

active

047676221

ABSTRACT:
Disclosed are vaccine compositions for use in developing protective immunity against infection by Plasmodium parasites. Soluble proteinaceous immunogens are isolated from the fluid culture medium of in vitro propagated plasmodial species parasites (e.g., P.falciparum) in mammalian erythrocyte culture supernatant or from washes, including hypotonic washes, of cultured erythrocytes parasitized by plasmodium. Immunogens so obtained have molecular weights in the range from about 35,000 daltons to about 85,000 daltons. Two principal immunogens of the invention have molecular weights of about 42,000 and 54,000 daltons, respectively. The water soluble immunogens are administered in a suitable carrier such as isotonic salt solution and in combination with a suitable adjuvant such as saponin or, preferably, aluminum hydroxide. Upon administration to vertebrate animals susceptible to plasmodial infection, vaccines according to the invention provoke immune responses protective against morbidity and mortality caused by, e.g., P.falciparum infection. Disclosed also are procedures for optimization of large scale plasmodial parasite growth in human erythrocyte cultures with accompanying development of late erythrocytic stage parasites in large numbers and optimization of isolatable quantities of culture medium supernatant and wash-derived immunogens.

REFERENCES:
patent: 4466917 (1984-08-01), Nussenzweig et al.
patent: 4596707 (1986-06-01), Ristic et al.
patent: 4643896 (1987-02-01), Asakura et al.
patent: 4693997 (1987-09-01), McCutchan et al.
Grothaus et al., Infection and Immunity, vol. 28(1), Apr. 1980, pp. 245-253, "Isolation of a Soluble Component of Plasmodium berghei . . . Rats".
Holder et al., Nature, vol. 294, Nov. 26, 1981, pp. 361-363, "Immunization Against Blood-Stage Rodent Malaria Using Purified Parasite Antigens".
Weiss et al., Exp. Parasitol., vol. 51, 1981, pp. 400-407, "Plasmodium falciparum: Assay in vitro for Inhibitors of Merozoitic Penetration of Erythrocytes ".
Siddiqui et al., Nature, vol. 289, Jan. 1/8, 1981, "Use of a Synthetic Adjuvant in an Effective Immunization of Monkeys against Malaria", pp. 64-66.
Tungery et al., Proc. Natl. Acad. Sci., Feb. 1983, vol. 80. pp. 1018-1022, "A Lectin-Like Receptor is Involved in the Invasion of Erythrocytes by Plasmodium falciparum".
Perrin et al., Trans. Roy. Soc. Trop. Med. Hyg., vol. 75(1), 1981, "Characterization of Antigens from Erythroytic Stages of Plasmodium falciparum Reacting with Immune Human Sera".
Wallach et al., J. Mol. Med., vol. 2, pp. 119-136, 1977.
McColm et al., Parasite Imm., vol. 4, pp. 337-345.
Perrin et al., Chem. Abst., vol. 94, No. 206968w, "Characterization of Antigens . . . Immune Serums".
Science, vol. 193, Aug. 20, 1976, pp. 673-675, Trager, William et al., "Human Malaria Parasites in Continuous Culture".

Affiliated with

Also associated with

Rating

Method and materials for development of immunological responses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and materials for development of immunological responses , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and materials for development of immunological responses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2087491